Search for information about a product,
therapeutic area or event

Search

Media, investors, advocacy organizations and others, please contact us here.

Posters

Alport Syndrome Natural History from the Rare Disease Registry: Associations with gene, variant type, and sex

Learn More
Posters IgAN

Estimating delay in time to kidney failure ordeath for treatment effects on proteinuria inIgA nephropathy

Learn More
Posters IgAN

Matching-adjusted indirect comparison of sparsentan vs. delayed-release formulation budesonide for proteinuria reduction in adults with IgA nephropathy

Learn More
Posters FSGS IgAN

Understanding the Impact of Immunoglobulin A Nephropathy (IgAN) and Focal Segmental Glomerulosclerosis (FSGS) on Patients and Care-Partners Study(HONUS): Updated Results for IgAN in the United States (US)

Learn More
Posters CTX

Prevalence of Cerebrotendinous Xanthomatosis (CTX) Among Patients Diagnosed With Juvenile-Onset Idiopathic Bilateral Cataracts

Learn More
Posters

Genetic Testing Identified Causative Variants in Nearly 20% of Early-Onset Bilateral Cataracts Cases

Learn More
Posters

Long-Term Efficacy and Safety of Sparsentan in Young Patients With FSGS: 240-Week Analysis of the DUET Open-Label Extension (OLE)

Learn More
Posters

Sparsentan Publications 2023

Learn More
Posters HCU

Population-based Incidence Estimates of Classical Homocystinuria Using the Genome Aggregation Database (gnomAD)

Learn More
Posters HCU

A Longitudinal Study of Cognitive Function in Classical Homocystinuria (HCU) Demonstrates Distinct Deficits in Inhibitory Control

Learn More
Posters HCU

Insights from the First Genetic Evaluation of a Longitudinal Natural History Study in Classical Homocystinuria (HCU)

Learn More
Posters HCU

Population-based Incidence Estimates of Classical Homocystinuria Using the Genome Aggregation Database (gnomAD)

Learn More
Posters HCU

A Longitudinal Study of Cognitive Function in Classical Homocystinuria (HCU) Demonstrates Distinct Deficits in Inhibitory Control

Learn More